Editorial Staff

  • Clinical Editor:

    Morton Kern, MD
  • Executive Editor:

    Laurie Gustafson
  • Managing Editor:

    Rebecca Kapur
  • Production Manager:

    Elizabeth Vasil
  • Editorial Correspondence

  • Rebecca Kapur, Managing Editor, Cath Lab Digest
  • HMP Communications, 83 General Warren Blvd

    Suite 100, Malvern PA 19355
  • Telephone: (800) 459-8657

    Fax: (866) 896-8762
  • Email: rkapur@hmpcommunications.com
  • June, 2004
    |
    Volume 12
    Issue 6

    Cross-training

    There is some controversy over the role(s) available in the cath lab for different credentials and just to what extent they can and should be cross-trained. What do you feel are the proper role(s) or responsibilities for RNs, RCISs, and RT(R)s in the cath lab? What about other credentials like physician assistants (PAs)?

    CVT Program is valuable

    I am currently in school for a CVT program and I think what has been taught through the school is more beneficial than being trained on the job. With the CVT program, you learn about diagnosing and more preventio

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   1,256 reads

    Elisabeth M. Frails, RCVT/RCIS, Cardiovascular Educator, University Hospital, Augusta, Georgia

    Those of us who have been in the cath lab setting for the past 15 years or more have witnessed dramatic changes, the majority of which are for the better, but some of which we may not be too sure. However, there are certainly many positive developments which have resulted in an improved work environment, such as streamlined operations, identification and definition of specific accountabilities and responsibilities, and a redefining of the team concept. Positive changes have also occurred in imaging technology, as well as with device improvements, such as drug-eluting stents and plaque abl

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   1,759 reads

    Sunny Koshy BS, RT(R)(CT)(CV)(CI)(ARRT), CCT, RCIS
    Cardiovascular Specialist
    Winston-Salem, North Carolina

    What is the size of your cath lab facility and number of staff members?

    We have five suites with a total of 44 staff members, including technical and nursing staff, support personnel, and students. We only have two credentials in our lab: ARRT-registered radiologic technologist and registered nurse. We have staff members with varied years of experience, ranging from 2 to 30.

    What type of procedures are performed at your facility?

    We perform diagnostic right and left heart catheterizations, percutaneous coronary interventions, pediatric diagnostic catheterizations, pedi

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   4,952 reads

    Donna Florio-Bronen, RN, ANCC, Anthony Pucillo, MD, Westchester Medical Center, Valhalla, New York

    Purpose: To describe how the cardiac catheterization lab at Westchester Medical Center increased hospital revenues as a result of changing its groin management protocol.

    Methods: In June 2000, Westchester Medical Center (WMC) implemented an arterial closure program. The primary endpoint of this program was to measure changes in the profitability of the cardiac catheterization lab (CCL) at WMC based upon implementation of a new groin management program. Profitability was measured by analysis of average Medicare reimbursement, average hospital cost for a catheterization proce

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   5,388 reads

    Sameer Mehta, MD, FACC, Director Cardiac Cath Lab, Samir M. Yebara, MD, Mohammed Ibrahim, MD, Martha Reyes, MD, Mercy Medical Center, Miami, Florida; Annmarie Galli, BSN, MBA, The Medicines Company, Parsippany, New Jersey

    It is now widely accepted that early sheath removal after percutaneous coronary intervention (PCI) reduces femoral access site complications and leads to earlier ambulation, possibly earlier discharge, and improved patient satisfaction. Heparin-based anticoagulation therapy requires monitoring of coagulation status to determine readiness for sheath removal, due to the unpredictable nature of heparin. In an effort to increase quality of care for his patients undergoing PCI, as well as reduce the cost of resources in the cath lab, Dr. Sameer Mehta developed a time-based sheath removal proto

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   8,525 reads

    Atul Sharma, MD and S.Chiu Wong, MD, Maurice R. and Corinne P. Greenberg Division of Cardiology
    Department of Medicine, The New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York

    This presentation contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the North American Center for Continuing Medical Education nor Cordis Corporation recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

    Topics: The Impact of Sirolimus-Eluting Stents on Patients at High Risk for Restenosis with Bare Metal Stenting

    Faculty/Credentials: Atul Sharma, MD and S.C

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   3,849 reads

    Coleman DeMoss, RA, Principal, Perkins & Will, Atlanta, Georgia

    Smaller, sleeker technologies in conjunction with increasingly sophisticated medical procedures have changed the face of cardiac catheterization labs.

    Changing Spaces

    In the above floor plans, which represent a health care provider both in the mid-1990’s and today, we can compare and contrast the way in which cardiac cath labs have changed over the past 10 years. While lab configuration has not changed radically, subtle differences in design can allow a lab to operate more efficiently.

    Central to the design of modern cath labs is the shrinking of electronic e

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   6,437 reads

    Jonathan Rourke, Chief Operating Officer , Viacor, Inc, Wilmington, Massachusetts

    What is transvenous annuloplasty?

    Transvenous annuloplasty, conceptually, is an alternative to conventional surgical annuloplasty. Currently, it is only an early development stage activity at multiple companies and centers; no products of this type have been permanently implanted in human subjects. Various approaches are being explored by Viacor and other investigators and companies. The objective is to substitute a percutaneous procedure for a surgical, bypass procedure in appropriate patients. The primary target for our device is ischemic mitral regurgitation.

    Our device, the

    continue reading
    Volume 12 - Issue 6 - June, 2004   |   2,682 reads